FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997807893> ?p ?o ?g. }

• W2997807893 endingPage "26" @default.
• W2997807893 startingPage "26" @default.
• W2997807893 abstract "Introduction The Xpert™ Clostridium difficile kit is a nucleic acid amplification test indicated after discrepant results from an enzymatic test; was submitted for incorporation in a teaching hospital in Brazil. In order to evaluate the potential for improvement with Xpert™ incorporation, the performance of the available technology (enzymatic test) was assessed using a real word evidence approach. Additionally, the association between enzymatic test results and the agreement to the Infectious Diseases Society of America (IDSA) recommendations for stool test submission (≥ 3 unformed stools in 24 hours without laxatives) for Clostridium difficile were evaluated. Methods This is a retrospective cohort study conducted at a tertiary teaching hospital. We included all consecutive tested patients that were submitted for enzyme immunoassay – glutamate dehydrogenase (GDH) plus toxin detection from 15 March to 8 May 2018. Data referent to episodes of unformed stools in 24 hours and use of laxatives were recorded. Statistical significance was tested by Fisher Exact test (α = 0.05). Results One hundred and thirty-eight consecutive patients were tested: 4 (2.9 percent) were positive for GDH and toxin (group III); 114 (82.6 percent) were negative for both (group I). Twenty (14.5 percent) cases were discrepant, all being positive to GDH and negative for toxin (group II). There were not negative GDH and positive toxin cases. The IDSA guidelines were followed in 33 (28.9%), 3 (15%) and 3(75%) test orders in groups I, II and III, respectively (p = 0.03). Conclusions Only a minority of patients had discrepant results in enzymatic tests and would be candidates for the Xpert™ test. The low adherence to IDSA guidelines could explain the low positivity rate of enzymatic tests at the hospital. Considering the uncertainty about the potential of the new test for changing infection control practices, Xpert™ was not recommended for incorporation. Using real world evidence data is important for contextualized health technology studies in hospitals." @default.
• W2997807893 created "2020-01-10" @default.
• W2997807893 creator A5048361314 @default.
• W2997807893 creator A5050697765 @default.
• W2997807893 creator A5064415577 @default.
• W2997807893 creator A5076991581 @default.
• W2997807893 date "2019-01-01" @default.
• W2997807893 modified "2023-10-18" @default.
• W2997807893 title "OP106 The Xpert™ Clostridium difficile Kit Incorporation: Conducting a Local Clinical Study as Part of Hospital Health Technology Assessment" @default.
• W2997807893 doi "https://doi.org/10.1017/s026646231900151x" @default.
• W2997807893 hasPublicationYear "2019" @default.
• W2997807893 type Work @default.
• W2997807893 sameAs 2997807893 @default.
• W2997807893 citedByCount "0" @default.
• W2997807893 crossrefType "journal-article" @default.
• W2997807893 hasAuthorship W2997807893A5048361314 @default.
• W2997807893 hasAuthorship W2997807893A5050697765 @default.
• W2997807893 hasAuthorship W2997807893A5064415577 @default.
• W2997807893 hasAuthorship W2997807893A5076991581 @default.
• W2997807893 hasConcept C126322002 @default.
• W2997807893 hasConcept C159654299 @default.
• W2997807893 hasConcept C170493617 @default.
• W2997807893 hasConcept C203014093 @default.
• W2997807893 hasConcept C2777202666 @default.
• W2997807893 hasConcept C2780420688 @default.
• W2997807893 hasConcept C2994496256 @default.
• W2997807893 hasConcept C501593827 @default.
• W2997807893 hasConcept C61174792 @default.
• W2997807893 hasConcept C71924100 @default.
• W2997807893 hasConcept C86803240 @default.
• W2997807893 hasConcept C89423630 @default.
• W2997807893 hasConcept C90924648 @default.
• W2997807893 hasConceptScore W2997807893C126322002 @default.
• W2997807893 hasConceptScore W2997807893C159654299 @default.
• W2997807893 hasConceptScore W2997807893C170493617 @default.
• W2997807893 hasConceptScore W2997807893C203014093 @default.
• W2997807893 hasConceptScore W2997807893C2777202666 @default.
• W2997807893 hasConceptScore W2997807893C2780420688 @default.
• W2997807893 hasConceptScore W2997807893C2994496256 @default.
• W2997807893 hasConceptScore W2997807893C501593827 @default.
• W2997807893 hasConceptScore W2997807893C61174792 @default.
• W2997807893 hasConceptScore W2997807893C71924100 @default.
• W2997807893 hasConceptScore W2997807893C86803240 @default.
• W2997807893 hasConceptScore W2997807893C89423630 @default.
• W2997807893 hasConceptScore W2997807893C90924648 @default.
• W2997807893 hasIssue "S1" @default.
• W2997807893 hasLocation W29978078931 @default.
• W2997807893 hasOpenAccess W2997807893 @default.
• W2997807893 hasPrimaryLocation W29978078931 @default.
• W2997807893 hasRelatedWork W1967205198 @default.
• W2997807893 hasRelatedWork W2028632020 @default.
• W2997807893 hasRelatedWork W2029718679 @default.
• W2997807893 hasRelatedWork W2093631066 @default.
• W2997807893 hasRelatedWork W2100893002 @default.
• W2997807893 hasRelatedWork W2101319830 @default.
• W2997807893 hasRelatedWork W2587184479 @default.
• W2997807893 hasRelatedWork W2738967161 @default.
• W2997807893 hasRelatedWork W2892153940 @default.
• W2997807893 hasRelatedWork W3199378984 @default.
• W2997807893 hasVolume "35" @default.
• W2997807893 isParatext "false" @default.
• W2997807893 isRetracted "false" @default.
• W2997807893 magId "2997807893" @default.
• W2997807893 workType "article" @default.